Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Elegen

Elegen

Elegen is a company is developing a patent-pending microfluidics technology for usage in synthetic biology. The technology is focused on engineering of genomes and development of immunotherapies for cancer.

OverviewStructured DataIssuesContributorsActivity

Elegen is a company is developing a patent-pending microfluidics technology for usage in synthetic biology. The technology is focused on engineering of genomes and development of immunotherapies for cancer.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Elegen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo